Pharmacotherapeutics for
Advanced Practice Nurse
Prescribers with Davis Edge
6th Edition
• Author(s)Teri Moser Woo; Wendy
L. Wright
TEST BANK
▪ The Foundation
▪ Pharmacotherapeutics with Single Drugs
▪ Pharmacotherapeutics with Multiple Drugs
▪ Special Drug Treatment Considerations
,Question 1
A newly graduated family nurse practitioner (FNP) is applying for
prescriptive authority in a state that requires physician collaboration
for certain controlled substances. Which action best demonstrates
appropriate professional responsibility before initiating prescribing?
A. Prescribe independently because APRN licensure automatically
grants full prescribing authority in all states
B. Review state regulations, collaborative practice requirements, and
DEA requirements before prescribing
C. Prescribe medications under the supervising physician’s DEA number
D. Limit prescribing to nonprescription medications until national
certification is obtained
Correct Answer: B
Rationale:
Prescribing authority varies by state and may involve collaborative
agreements, controlled substance restrictions, and DEA registration
requirements. APRNs are responsible for understanding applicable laws
before prescribing. Option A is incorrect because authority varies by
state. Option C is illegal. Option D is unnecessary once licensure and
certification requirements are met.
Question 2
A nurse practitioner is evaluating a 68-year-old patient with multiple
chronic illnesses who receives prescriptions from three specialists.
,What is the most appropriate first step before prescribing a new
medication?
A. Prescribe the medication at the lowest available dose
B. Obtain a complete medication reconciliation
C. Request specialist approval before prescribing
D. Avoid prescribing any additional medications
Correct Answer: B
Rationale:
Medication reconciliation is essential to identify duplication,
interactions, contraindications, and adherence issues. APRNs should
review all prescription medications, over-the-counter products, and
supplements before prescribing. The other options do not adequately
address medication safety.
Question 3
An APRN is considering treatment options for a patient with
uncomplicated hypertension. Which principle best reflects evidence-
based prescribing?
A. Select the medication with the newest FDA approval
B. Choose the drug most commonly advertised to consumers
C. Integrate clinical evidence, patient factors, and patient preferences
D. Prescribe the medication preferred by the pharmacy benefit
manager
Correct Answer: C
, Rationale:
Evidence-based prescribing combines current research evidence,
clinical expertise, and patient values. Drug selection should consider
efficacy, safety, comorbidities, adherence, and cost. Options A, B, and D
fail to incorporate comprehensive patient-centered decision-making.
Question 4
A patient asks why an APRN spent time discussing treatment goals
before writing a prescription. Which response best explains patient-
centered prescribing?
A. "Insurance companies require extensive counseling."
B. "Treatment decisions should reflect both clinical evidence and your
preferences."
C. "Federal law requires all patients to participate in treatment
decisions."
D. "The purpose is to reduce documentation requirements."
Correct Answer: B
Rationale:
Shared decision-making improves adherence, patient satisfaction, and
clinical outcomes. Effective prescribing incorporates patient goals,
preferences, and values while applying evidence-based
recommendations. The remaining options are inaccurate.
Question 5
Advanced Practice Nurse
Prescribers with Davis Edge
6th Edition
• Author(s)Teri Moser Woo; Wendy
L. Wright
TEST BANK
▪ The Foundation
▪ Pharmacotherapeutics with Single Drugs
▪ Pharmacotherapeutics with Multiple Drugs
▪ Special Drug Treatment Considerations
,Question 1
A newly graduated family nurse practitioner (FNP) is applying for
prescriptive authority in a state that requires physician collaboration
for certain controlled substances. Which action best demonstrates
appropriate professional responsibility before initiating prescribing?
A. Prescribe independently because APRN licensure automatically
grants full prescribing authority in all states
B. Review state regulations, collaborative practice requirements, and
DEA requirements before prescribing
C. Prescribe medications under the supervising physician’s DEA number
D. Limit prescribing to nonprescription medications until national
certification is obtained
Correct Answer: B
Rationale:
Prescribing authority varies by state and may involve collaborative
agreements, controlled substance restrictions, and DEA registration
requirements. APRNs are responsible for understanding applicable laws
before prescribing. Option A is incorrect because authority varies by
state. Option C is illegal. Option D is unnecessary once licensure and
certification requirements are met.
Question 2
A nurse practitioner is evaluating a 68-year-old patient with multiple
chronic illnesses who receives prescriptions from three specialists.
,What is the most appropriate first step before prescribing a new
medication?
A. Prescribe the medication at the lowest available dose
B. Obtain a complete medication reconciliation
C. Request specialist approval before prescribing
D. Avoid prescribing any additional medications
Correct Answer: B
Rationale:
Medication reconciliation is essential to identify duplication,
interactions, contraindications, and adherence issues. APRNs should
review all prescription medications, over-the-counter products, and
supplements before prescribing. The other options do not adequately
address medication safety.
Question 3
An APRN is considering treatment options for a patient with
uncomplicated hypertension. Which principle best reflects evidence-
based prescribing?
A. Select the medication with the newest FDA approval
B. Choose the drug most commonly advertised to consumers
C. Integrate clinical evidence, patient factors, and patient preferences
D. Prescribe the medication preferred by the pharmacy benefit
manager
Correct Answer: C
, Rationale:
Evidence-based prescribing combines current research evidence,
clinical expertise, and patient values. Drug selection should consider
efficacy, safety, comorbidities, adherence, and cost. Options A, B, and D
fail to incorporate comprehensive patient-centered decision-making.
Question 4
A patient asks why an APRN spent time discussing treatment goals
before writing a prescription. Which response best explains patient-
centered prescribing?
A. "Insurance companies require extensive counseling."
B. "Treatment decisions should reflect both clinical evidence and your
preferences."
C. "Federal law requires all patients to participate in treatment
decisions."
D. "The purpose is to reduce documentation requirements."
Correct Answer: B
Rationale:
Shared decision-making improves adherence, patient satisfaction, and
clinical outcomes. Effective prescribing incorporates patient goals,
preferences, and values while applying evidence-based
recommendations. The remaining options are inaccurate.
Question 5
